Pharma Sponsor Enlists Cenduit IRT To Rescue A Multi-Country, Multi-Site Oncology Study

The sponsor assessed the safety and tolerability of escalating oral doses of one drug, when combined with the standard dosing of another, in patients with advanced solid malignancies. The client : a global pharmaceutical group focused on developing prescription drugs that target unmet medical needs in numerous indications including oncology.

CHALLENGE: ADAPTIVE DESIGN

• After go-live, the sponsor learned its study did not fit the existing IRT solution, affecting data quality, timelines, and drug supply shipments. Following an RFP, the sponsor asked Cenduit to build a rescue study
• A key factor: the legacy system’s medication management algorithm could not support the required flexibility in the supply chain. The trial included an adaptive cohort design

RESULTS

• Cenduit delivered a high-quality study achieved through innovation, close client collaboration, and expert project management.